07 August 2018
Visiongain’ has launched a new pharma report Bioreactors Market Report : 5L-20L, 20L-200L, 200L-1500L, Above 1500L, Single-Use, Glass, Stainless Steel, Lab-Scale, Pilot-Scale, Full-Scale, R&D Departments, Biopharmaceutical Manufacturers, Contract Research Organizations, Other End-Users
The bioreactors market is driven by the increasing use of hybrid technologies, a rise in the rate of adoption of single-use technologies, increasing popularity of single-use bioreactor among biopharmaceutical organizations, and a significant growth in the biologics market. The global bioreactor market is dominated by the single-use bioreactors that hold a major share owing to their high usage in various applications. The main factor driving the increased usage of single-use bioreactors includes low upfront investment cost. There is a high adoption rate of single-use bioreactors owing to reduced capital expenditure costs due to the lower costs of cleaning and sterilizing bioreactors and enhancement of the flexibility in operations during drug manufacturing process.
The lead analyst of the report commented “Asia-Pacific and Rest of the World (RoW) are the emerging bioreactor markets. These regions hold tremendous potential to become the bioreactors market giants in the future. Asia-Pacific countries are estimated to demonstrate tremendous growth for bioreactors owing to the massive expansion of the biopharmaceutical sector in this region.
The rising interest of pharmaceutical organizations to enter the biopharmaceutical market will result in consolidation in the form of strategic alliances between contract manufacturing organizations (CMO’s) and large pharmaceutical/biotechnology organizations. This will result in increased investments and access to cutting-edge manufacturing technologies for CMOs. ”
Leading companies featured in the report include Sartorius AG, Thermo Fisher Scientific, Inc., Merck KGaA, GE Healthcare, Danaher Corporation, Eppendorf AG, Applikon Biotechnology Inc., Solaris Biotech, Bioengineering AG, and Infors HT
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to email@example.com or call her on +44 (0) 207 336 6100
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-to-business reports cusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
Automation is a rising trend in the supply chain as a way to reduce time to market and enhance efficiency. Automation is appealing for a variety of reasons, the most important of which is that it reduces human contact and hence interference.
02 September 2021
As governments in emerging countries are taking measures to improve healthcare, it is positively impacting the anti-epileptic drugs market growth.
24 August 2021
From a long-term perspective, the rapid growth of the mid-class economy will enhance the demand for OTC products in emerging economies such as China, India and Brazil.
24 August 2021
Growing female population with faecal incontinence to fuel bowel management systems market growth through 2031.